AbbVie partnered with Iambic, a company that is IPO-bound, to apply AI to drug discovery.
Summaries like this, in your inbox every morning.
For example, today's edition would include:
AI-summarized, only the topics you pick: one digest a day via Email, LINE, or Slack.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Daniel Roher's Netflix documentary 'The AI Doc: Or How I Became an Apocaloptimist' presents both AI safety exp…
NVIDIA announced the NVIDIA Open Agent Safety Platform, an open software platform and reference design to secu…
Bank of America announced Payments Insights, a new CashPro capability that analyzes payment efficiency, cross-…
NVIDIA announced its NVIDIA Open Agent Safety Platform, combining OpenShell open-source software for secure ag…
Dell's AI server backlog rose to $95 billion after a record $60.9 billion in AI server orders in fiscal Q2, wi…
Cantor says Marvell's AI opportunity could expand to $625B by 2030, with revenue growing at up to a 45% CAGR
